Ligation of CD38 suppresses human B lymphopoiesis

doi:10.1084/jem.181.3.1101

This Article

	Full Text (PDF, 1042K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Kumagai, M.
	Articles by Campana, D.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Kumagai, M.
	Articles by Campana, D.


Social Bookmarking

	What's this?

ARTICLES

Ligation of CD38 suppresses human B lymphopoiesis

M Kumagai, E Coustan-Smith, DJ Murray, O Silvennoinen, KG Murti, WE Evans, F Malavasi and D Campana
Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101.

CD38 is a transmembrane glycoprotein expressed in many cell types, including lymphoid progenitors and activated lymphocytes. High levels of CD38 expression on immature lymphoid cells suggest its role in the regulation of cell growth and differentiation, but there is no evidence demonstrating a functional activity of CD38 on these cells. We used stroma-supported cultures of B cell progenitors and anti-CD38 monoclonal antibodies (T16 and IB4) to study CD38 function. In cultures of normal bone marrow CD19+ cells (n = 5), addition of anti-CD38 markedly reduced the number of cells recovered after 7 d. Cell loss was greatest among CD19+ sIg- B cell progenitors (mean cell recovery +/- SD = 7.2 +/- 11.7% of recovery in control cultures) and extended to CD19+CD34+ B cells (the most immature subset; 7.6 +/- 2.2%). In contrast, CD38 ligation did not substantially affect cell numbers in cultures of normal peripheral blood or tonsillar B cells. In stroma- supported cultures of 22 B-lineage acute lymphoblastic leukemia cases, anti-CD38 suppressed recovery of CD19+ sIg- leukemic cells. CD38 ligation also suppressed the growth of immature lymphoid cell lines cultured on stroma and, in some cases, in the presence of stroma- derived cytokines (interleukin [IL] 7, IL-3, and/or stem cell factor), but did not inhibit growth in stroma- or cytokine-free cultures. DNA content and DNA fragmentation studies showed that CD38 ligation of stroma-supported cells resulted in both inhibition of DNA synthesis and induction of apoptosis. It is known that CD38 catalyzes nicotinamide adenine dinucleotide (NAD+) hydrolysis into cyclic ADP-ribose (cADPR) and ADPR. However, no changes in NAD+ hydrolysis or cADPR and ADPR production after CD38 ligation were found by high-performance liquid chromatography; addition of NAD+, ADPR, or cADPR to cultures of lymphoid progenitors did not offset the inhibitory effects of anti- CD38. Thus, anti-CD38 does not suppress B lymphopoiesis by altering the enzymatic function of the molecule. In conclusion, these data show that CD38 ligation inhibits the growth of immature B lymphoid cells in the bone marrow microenvironment, and suggest that CD38 interaction with a putative ligand represents a novel regulatory mechanism of B lymphopoiesis.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Malavasi, F., Deaglio, S., Funaro, A., Ferrero, E., Horenstein, A. L., Ortolan, E., Vaisitti, T., Aydin, S. (2008). Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology. Physiol. Rev. 88: 841-886 [Abstract] [Full Text]
Mayo, L., Jacob-Hirsch, J., Amariglio, N., Rechavi, G., Moutin, M.-J., Lund, F. E., Stein, R. (2008). Dual Role of CD38 in Microglial Activation and Activation-Induced Cell Death. J. Immunol. 181: 92-103 [Abstract] [Full Text]
Patten, P. E. M., Buggins, A. G. S., Richards, J., Wotherspoon, A., Salisbury, J., Mufti, G. J., Hamblin, T. J., Devereux, S. (2008). CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood 111: 5173-5181 [Abstract] [Full Text]
Rodriguez-Alba, J. C., Moreno-Garcia, M. E., Sandoval-Montes, C., Rosales-Garcia, V. H., Santos-Argumedo, L. (2008). CD38 induces differentiation of immature transitional 2 B lymphocytes in the spleen. Blood 111: 3644-3652 [Abstract] [Full Text]
Deaglio, S., Vaisitti, T., Aydin, S., Ferrero, E., Malavasi, F. (2006). In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia. Blood 108: 1135-1144 [Abstract] [Full Text]
Lund, F. E., Muller-Steffner, H., Romero-Ramirez, H., Moreno-Garcia, M. E., Partida-Sanchez, S., Makris, M., Oppenheimer, N. J., Santos-Argumedo, L., Schuber, F. (2006). CD38 induces apoptosis of a murine pro-B leukemic cell line by a tyrosine kinase-dependent but ADP-ribosyl cyclase- and NAD glycohydrolase-independent mechanism. Int Immunol 18: 1029-1042 [Abstract] [Full Text]
Zhang, G., Teggatz, E. G., Zhang, A. Y., Koeberl, M. J., Yi, F., Chen, L., Li, P.-L. (2006). Cyclic ADP ribose-mediated Ca2+ signaling in mediating endothelial nitric oxide production in bovine coronary arteries. Am. J. Physiol. Heart Circ. Physiol. 290: H1172-H1181 [Abstract] [Full Text]
Deaglio, S., Vaisitti, T., Bergui, L., Bonello, L., Horenstein, A. L., Tamagnone, L., Boumsell, L., Malavasi, F. (2005). CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood 105: 3042-3050 [Abstract] [Full Text]
Sutherland, T. E., Schuliga, M., Harris, T., Eckhardt, B. L., Anderson, R. L., Quan, L., Stewart, A. G. (2005). 2-Methoxyestradiol Is an Estrogen Receptor Agonist That Supports Tumor Growth in Murine Xenograft Models of Breast Cancer. Clin. Cancer Res. 11: 1722-1732 [Abstract] [Full Text]
Deaglio, S., Capobianco, A., Bergui, L., Durig, J., Morabito, F., Duhrsen, U., Malavasi, F. (2003). CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood 102: 2146-2155 [Abstract] [Full Text]
Marchetti, P., Antonelli, A., Lupi, R., Marselli, L., Fallahi, P., Nesti, C., Baj, G., Ferrannini, E. (2002). Prolonged In Vitro Exposure to Autoantibodies Against CD38 Impairs the Function and Survival of Human Pancreatic Islets. Diabetes 51: S474-477 [Abstract] [Full Text]
Del Poeta, G., Maurillo, L., Venditti, A., Buccisano, F., Epiceno, A. M., Capelli, G., Tamburini, A., Suppo, G., Battaglia, A., Del Principe, M. I., Del Moro, B., Masi, M., Amadori, S. (2001). Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood 98: 2633-2639 [Abstract] [Full Text]
Ibrahim, S., Keating, M., Do, K.-A., O'Brien, S., Huh, Y. O., Jilani, I., Lerner, S., Kantarjian, H. M., Albitar, M. (2001). CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 98: 181-186 [Abstract] [Full Text]
Musso, T., Deaglio, S., Franco, L., Calosso, L., Badolato, R., Garbarino, G., Dianzani, U., Malavasi, F. (2001). CD38 expression and functional activities are up-regulated by IFN-{gamma} on human monocytes and monocytic cell lines. J. Leukoc. Biol. 69: 605-612 [Abstract] [Full Text]
Mallone, R., Funaro, A., Zubiaur, M., Baj, G., Ausiello, C. M., Tacchetti, C., Sancho, J., Grossi, C., Malavasi, F. (2001). Signaling through CD38 induces NK cell activation. Int Immunol 13: 397-409 [Abstract] [Full Text]
Srivannaboon, K., Shanafelt, A. B., Todisco, E., Forte, C. P., Behm, F. G., Raimondi, S. C., Pui, C.-H., Campana, D. (2001). Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acute lymphoblastic leukemia cells. Blood 97: 752-758 [Abstract] [Full Text]
Todisco, E., Suzuki, T., Srivannaboon, K., Coustan-Smith, E., Raimondi, S. C., Behm, F. G., Kitanaka, A., Campana, D. (2000). CD38 ligation inhibits normal and leukemic myelopoiesis. Blood 95: 535-542 [Abstract] [Full Text]
Damle, R. N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S. L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S. M., Schulman, P., Vinciguerra, V. P., Rai, K. R., Ferrarini, M., Chiorazzi, N. (1999). Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia. Blood 94: 1840-1847 [Abstract] [Full Text]
Mizoguchi, C., Uehara, S., Akira, S., Takatsu, K. (1999). IL-5 Induces IgG1 Isotype Switch Recombination in Mouse CD38-Activated sIgD-Positive B Lymphocytes. J. Immunol. 162: 2812-2819 [Abstract] [Full Text]
Kitanaka, A., Suzuki, T., Ito, C., Nishigaki, H., Coustan-Smith, E., Tanaka, T., Kubota, Y., Campana, D. (1999). CD38-Mediated Signaling Events in Murine Pro-B Cells Expressing Human CD38 With or Without Its Cytoplasmic Domain. J. Immunol. 162: 1952-1958 [Abstract] [Full Text]
Ito, C., Kumagai, M.-a., Manabe, A., Coustan-Smith, E., Raimondi, S. C., Behm, F. G., Murti, K. G., Rubnitz, J. E., Pui, C.-H., Campana, D. (1999). Hyperdiploid Acute Lymphoblastic Leukemia With 51�to 65�Chromosomes: A Distinct Biological Entity With a Marked Propensity to Undergo Apoptosis. Blood 93: 315-320 [Abstract] [Full Text]
Franco, L., Guida, L., Bruzzone, S., Zocchi, E., Usai, C., Flora, A. D. (1998). The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes. FASEB J. 12: 1507-1520 [Abstract] [Full Text]
Konopleva, M., Estrov, Z., Zhao, S., Andreeff, M., Mehta, K. (1998). Ligation of Cell Surface CD38 Protein with Agonistic Monoclonal Antibody Induces a Cell Growth Signal in Myeloid Leukemia Cells. J. Immunol. 161: 4702-4708 [Abstract] [Full Text]
Cockayne, D. A., Muchamuel, T., Grimaldi, J. C., Muller-Steffner, H., Randall, T. D., Lund, F. E., Murray, R., Schuber, F., Howard, M. C. (1998). Mice Deficient for the Ecto-Nicotinamide Adenine Dinucleotide Glycohydrolase CD38 Exhibit Altered Humoral Immune Responses. Blood 92: 1324-1333 [Abstract] [Full Text]
Kishimoto, H., Hoshino, S.-i., Ohori, M., Kontani, K., Nishina, H., Suzawa, M., Kato, S., Katada, T. (1998). Molecular Mechanism of Human CD38 Gene Expression by Retinoic Acid. IDENTIFICATION OF RETINOIC ACID RESPONSE ELEMENT IN THE FIRST INTRON. J. Biol. Chem. 273: 15429-15434 [Abstract] [Full Text]
Morra, M., Zubiaur, M., Terhorst, C., Sancho, J., Malavasi, F. (1998). CD38 is functionally dependent on the TCR/CD3 complex in human T cells. FASEB J. 12: 581-592 [Abstract] [Full Text]
Cesano, A., Visonneau, S., Deaglio, S., Malavasi, F., Santoli, D. (1998). Role of CD38 and Its Ligand in the Regulation of MHC-Nonrestricted Cytotoxic T Cells. J. Immunol. 160: 1106-1115 [Abstract] [Full Text]
Kitanaka, A., Mano, H., Ellen Conley, M., Campana, D. (1998). Expression and Activation of the Nonreceptor Tyrosine Kinase Tec in Human B Cells. Blood 91: 940-948 [Abstract] [Full Text]
Ito, C., Ribeiro, R. C., Behm, F. G., Raimondi, S. C., Pui, C.-H., Campana, D. (1998). Cyclosporin A Induces Apoptosis in Childhood Acute Lymphoblastic Leukemia Cells. Blood 91: 1001-1007 [Abstract] [Full Text]
Nishigaki, H., Ito, C., Manabe, A., Kumagai, M.-a., Coustan-Smith, E., Yanishevski, Y., Behm, F. G., Raimondi, S. C., Pui, C.-H., Campana, D. (1997). Prevalence and Growth Characteristics of Malignant Stem Cells in B-Lineage Acute Lymphoblastic Leukemia. Blood 89: 3735-3744 [Abstract] [Full Text]
Hara-Yokoyama, M., Kukimoto, I., Nishina, H., Kontani, K., Hirabayashi, Y., Irie, F., Sugiya, H., Furuyama, S., Katada, T. (1996). Inhibition of NAD+ Glycohydrolase and ADP-ribosyl Cyclase Activities of Leukocyte Cell Surface Antigen CD38 by Gangliosides. J. Biol. Chem. 271: 12951-12955 [Abstract] [Full Text]
Kontani, K., Kukimoto, I., Nishina, H., Hoshino, S.-i., Hazeki, O., Kanaho, Y., Katada, T. (1996). Tyrosine Phosphorylation of the c-cbl Proto-oncogene Product Mediated by Cell Surface Antigen CD38 in HL-60 Cells. J. Biol. Chem. 271: 1534-1537 [Abstract] [Full Text]
Zilber, M.-T., Gregory, S., Mallone, R., Deaglio, S., Malavasi, F., Charron, D., Gelin, C. (2000). CD38 expressed on human monocytes: A coaccessory molecule in the superantigen-induced proliferation. Proc. Natl. Acad. Sci. USA 97: 2840-2845 [Abstract] [Full Text]